Sort
30,917 grants matching “tumor microenvironment”
Data-driven inference of regulators for cytokine-mediated tumor killing
$512,397Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
$512,292Nadia Carlesso · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
$512,286Gang Zhou · Augusta University · R01 · FY2023 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
$512,286Gang Zhou · Augusta University · R01 · FY2022 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$512,231George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$512,229George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$512,222Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA
Dual targeting of XPO1 and BTK in B cell malignancies
$512,016Rosa Lapalombella · Ohio State University · R01 · FY2018 · CA
Dual targeting of XPO1 and BTK in B cell malignancies
$512,016Rosa Lapalombella · Ohio State University · R01 · FY2017 · CA
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
$512,013Charles S Cobbs · Swedish Medical Center, First Hill · R01 · FY2015 · CA
The role of Interleukin 17RB signaling in colorectal cancer progression
$511,957Sergei I Grivennikov · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$511,811Weiqiang Chen · New York University · R01 · FY2022 · CA
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$511,752Kenneth J. Pienta · Johns Hopkins University · U01 · FY2014 · CA
âPharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment responseâ
$511,747Robert C Rostomily · Methodist Hospital Research Institute · R01 · FY2024 · NS
Inflammatory modulation of CXCL12 expressing niche cells in bone marrow
$511,746Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2017 · HL
Inflammatory modulation of CXCL12 expressing niche cells in bone marrow
$511,746Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2019 · HL
Inflammatory modulation of CXCL12 expressing niche cells in bone marrow
$511,746Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2020 · HL
Phosphorylation of TSC2 (S1365) as a novel Regulator of mTORC1 Signaling in T Cells
$511,727Erika L Pearce · Johns Hopkins University · R01 · FY2023 · AI
TOPAS - nBio, a Monte Carlo tool for radiation biology research
$511,714Jan Patrick Oscar Schuemann · Massachusetts General Hospital · R01 · FY2023 · CA
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
$511,692Shrikant Anant · University Of Kansas Medical Center · R01 · FY2014 · CA
Regulation of ER-beta Signaling in Carcinogenesis
$511,684Rong Li · George Washington University · R01 · FY2019 · CA
Project 1-Combination Immunotherapy with Radioligned Therapy for Metastatic Prostate Cancer
$511,680Lawrence Fong · University Of California, San Francisco · P50 · FY2024 · CA
Bitter taste receptors in oral cancer tumor-associated macrophages
$511,578Ryan Michael Carey · University Of Pennsylvania · R01 · FY2025 · DE
Immune biological differences between Triple Negative Breast Cancer in African American and non-African American women and potential immunotherapy opportunities to improve treatment outcome
$511,570Lajos Pusztai · Yale University · R01 · FY2019 · CA
Viscotaxis: Novel cell migration mechanisms regulated by microenvironmental viscosity
$511,567Konstantinos Konstantopoulos · Johns Hopkins University · R01 · FY2021 · CA